Shanghai, China

Yanxiao Su

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fujian Akeylink Biotechnology Co., Ltd.. Active years: 2024.


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Profile of Innovator Yanxiao Su: A Pioneer in Hepatitis B Research

Introduction: Yanxiao Su is a prominent inventor based in Shanghai, China, known for his groundbreaking work in the field of biotechnology. With a focus on hepatitis research, he has developed a significant invention that contributes to the fight against hepatitis B, showcasing the essential role of innovation in medical advancements.

Latest Patents: Yanxiao Su holds a notable patent for a crystal form of a hepatitis B surface antigen inhibitor. This invention not only discloses the unique crystal form but also outlines the preparation method and its implications for developing the hepatitis B surface antigen inhibitor. His work represents a valuable step forward in the ongoing quest to combat hepatitis B infections.

Career Highlights: Su is currently employed at Fujian Akeylink Biotechnology Co., Ltd., where he continues to contribute to biotechnological innovations. His expertise and dedication to research have established him as a figure of significance within the industry.

Collaborations: Throughout his career, Yanxiao Su has collaborated with talented individuals in the field, including coworkers Yanbin Hu and Fei Sun. These collaborations facilitate the sharing of ideas and expertise, driving forward the research and development of innovative solutions.

Conclusion: Yanxiao Su is an exemplary inventor whose contributions to hepatitis B research are crucial in the global effort to combat this disease. With his patent and ongoing work at Fujian Akeylink Biotechnology Co., Ltd., he demonstrates how innovation and collaboration can lead to significant advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…